No Data
No Data
Chardan Capital Initiates Coverage On Unity Biotechnology With Buy Rating, Announces Price Target of $6
Unity Biotechnology Analyst Ratings
Chardan Capital Initiates Unity Biotechnology(UBX.US) With Buy Rating, Announces Target Price $6
UNITY Biotechnology Reports Granting of New Employment Inducement Award
Unity Biotechnology Names Federico Grossi Chief Medical Officer, Pre-market Stock Rises
Express News | UNITY Biotechnology Announces Appointment of Federico Grossi, M.d., Ph.d., as Chief Medical Officer